CollPlant Biotechnologies Ltd. to Participate in 27th Annual H.C. Wainwright Global Investment Conference
Reuters
Aug 25
CollPlant Biotechnologies Ltd. to Participate in 27th Annual H.C. Wainwright Global Investment Conference
CollPlant Biotechnologies Ltd., a company specializing in regenerative and aesthetics medicine using non-animal-derived recombinant human collagen, will participate in the 27th Annual H.C. Wainwright Global Investment Conference. The event will be held on September 8th and 9th, 2025, at the Lotte New York Palace Hotel. Senior management from CollPlant will be present at the conference.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Collplant Biotechnologies Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: IO57967) on August 25, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.